Benefits include smaller incisions, less pain, quicker recovery, reduced risk of infection, and minimal scarring.

The HCV RNA Test detects and measures the presence of Hepatitis C virus RNA in the blood, indicating an active infection and viral load.

The test is used to confirm Hepatitis C infection, assess viral load, evaluate treatment response, and check for relapse.

No special preparation is needed. You can eat and drink normally. Inform your healthcare provider about any medications or recent health issues.

Results are usually available within 1 to 3 days after the test.

A high viral load indicates a higher quantity of Hepatitis C virus in the blood, suggesting more active infection and potentially more severe disease.

The target INR range for patients on warfarin therapy varies depending on their condition but is typically between 2.0 and 3.0.

Frequency of testing depends on individual patient needs, but initially, it may be done weekly or bi-weekly until stable, then less frequently thereafter.

Yes, the PT / INR Test can help diagnose various clotting disorders, including those related to liver disease or genetic clotting factor deficiencies.

Medications, dietary changes, liver function, and underlying health conditions can all influence PT / INR results.

Yes, the PT / INR Test is a safe and standard diagnostic procedure used worldwide to monitor blood clotting ability and adjust anticoagulant therapy.